Innate PharmaEigentümerstruktur
| Preis (2026-07-27) | 52W Hoch | 52W Tief |
| 1.772 USD | 2,63 USD | 1,17 USD |
| Analysten Konsens | Buy | Outperform | Hold | Underperform | Sell |
| 6 USD | 1 | 1 | 1 | 0 | 0 |
| #Shares | Short [%] | Short Ratio |
| 93.903.288 | 0,18 | 14,33 |
Eigentümerstruktur
Analyse der Aktionärsstruktur und institutionellen Investoren
Unternehmensdaten
Grundlegende Informationen
Grunddaten
Name Innate Pharma
Mitarbeiter 164
Handelsplatz NASDAQ
Ticker Symbol IPHA
IPO Datum 2019-10-17
Adresse 117, Avenue de Luminy, Marseille, France, 13009
Webseite https://www.innate-pharma.com
Unternehmensführung
| Rang | Name | Position |
|---|---|---|
| 1 | Mr. Jonathan E. Dickinson B.Sc., M.B.A. | CEO & Director |
| 2 | Mr. Yannis Morel Ph.D. | Executive VP & COO |
| 3 | Dr. Sonia Quaratino M.D., Ph.D. | Executive VP & Chief Medical Officer |
| 4 | Dr. François Romagné Ph.D. | Founder |
| 5 | Dr. Marc Bonneville Ph.D. | Founder |
| 6 | Mr. Jean Jacques Fournié Ph.D. | Founder |
| 7 | Mr. Alessandro Moretta M.D., Ph.D. | Founder |
| 8 | Mr. Frederic Lombard M.B.A. | Senior VP & CFO |
| 9 | Ms. Stephanie Cornen | Vice President of Investor Relations, Communication & Commercial Strategy |
| 10 | Ms. Odile Belzunce | VP, Chief of Compliance & Operations Officer and Interim Head of HR |
Aktionärsverteilung
Aufteilung der Investoren
Größte Investoren
| Rang | Inhaber | Anteile | Wert |
|---|---|---|---|
| 1 | Lion Point Capital, LP | 0,00% | 0,00 Mio. USD |
| 2 | Morgan Stanley - Brokerage Accounts | 0,00% | 0,00 Mio. USD |
| 3 | Jane Street Group LLC | 0,00% | 0,00 Mio. USD |
| 4 | Millennium Management LLC | 0,00% | 0,00 Mio. USD |
| 5 | Rhumbline Advisers | 0,00% | 0,00 Mio. USD |
| 6 | UBS Group AG | 0,00% | 0,00 Mio. USD |
| 7 | GAMMA Investing LLC | 0,00% | 0,00 Mio. USD |
| 8 | Caitong International Asset Management Co., Limited. | 0,00% | 0,00 Mio. USD |
| 9 | Sageview Advisory Group LLC | 0,00% | 0,00 Mio. USD |
| 10 | OLD MISSION CAPITAL LLC. | 0,00% | 0,00 Mio. USD |
| 11 | Barclays PLC | 0,00% | 0,00 Mio. USD |
| 12 | Citadel Advisors Llc | 0,00% | 0,00 Mio. USD |
| 13 | Optiver Holding B.V. | 0,00% | 0,00 Mio. USD |
| 14 | Principal Securities Inc | 0,00% | 0,00 Mio. USD |